Case Reports
Vol. 11 No. 3 (2017)
https://doi.org/10.4081/itjm.2017.775

Uncommon case of pericardial effusion

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 14 September 2016
Published: 11 September 2017
1804
Views
786
Downloads
544
HTML
Pericardial disease, cancer, inflammation, echocardiography.
Internal medicine,

Authors

Andrea D'Amato
damatoandrea@hotmail.com
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Costantino Mancusi
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Maria Viviana Carlino
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Veronica Lio
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Federica De Pisapia
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Alfonso Sforza
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
Giovanni de Simone
Hypertension Research Center, Department of Translational Medical Science, Federico II University, Napoli, Italy.
We present the case of a 59-year-old patient with severe aortic stenosis, asymptomatic mild to moderate pericardial effusion and no major risk factors for poor prognosis. He underwent four-week course of non-steroidal anti-inflammatory drugs (ibuprofen 600 mg TID) with no improvement of the effusion. After complete diagnostic work-up and examination, we discovered that he had a prostate cancer with bone metastasis. On the bone scintigraphy, there was particular involvement of ribs and sternum. We decided to treat our patient with an association of docetaxel and hormone therapy, after six months we observed a reduction in the pericardial effusion. Even in the presence of a patient without risk factor of poor prognosis, pericardial effusion can be the first sign of occult neoplasia.

Downloads

Download data is not yet available.

How to Cite



Uncommon case of pericardial effusion. (2017). Italian Journal of Medicine, 11(3), 331-334. https://doi.org/10.4081/itjm.2017.775

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.